The treatment of severe or recurrent deep venous thrombosis
As GLP-1 medications continue to be prescribed to millions of people worldwide, more data will accumulate on the incidence, risk factors, mechanisms, and optimal management of this side effect
[160 161] Primary care teams must now coordinate with more specialists than ever before, [162] despite persistent barriers to specialist access for certain patients
Pain medications mask symptoms without addressing the underlying cause, and steroid injections provide only temporary relief
Senescent erythrocytes are characterized by loss of surface area and volume [66], increased cell density [67], reduced deformability [68], cation loss [69], membrane desialylation [70], enzymatic dysregulation [69], oxidative stress [71], hemichrome abundance [69], elevated levels of glycated hemoglobin [72], reduced expression of phagocytosis-inhibiting CD47 [73], altered protein 4.1a/protein 4.1b ratio [74], etc